PAD4 inhibitor (C4X Discovery)

N/A

Report date: 2024/08/12 10:24:21
NME

Base Information

Drug NamePAD4 inhibitor (C4X Discovery)
Drug Alias NamePeptidylarginine deiminase type 4 inhibitor (C4X Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-arginine deiminase type-4 inhibitors
TargetsProtein-arginine deiminase type-4
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC4X Discovery Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesC4X Discovery Holdings plc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A